Advocacy intelligence hub — real-time data for patient organizations
ARIPIPRAZOLE: FDA approved
ABILIFY MAINTENA: New indication approved
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Abilify
(aripiprazole)Orphan drugOtsuka Pharmaceutical Development
Atypical Antipsychotic [EPC]
12.1 Mechanism of Action The mechanism of action of aripiprazole in schizophrenia or bipolar mania, is unclear. However, the efficacy of aripiprazole ...
View all NON RARE IN EUROPE: Tourette syndrome specialists →